The low-temperature (<-35 °C) reduction of the trivalent uranium monoarene complex [{((Ad,Me) ArO)3 mes}U] (1), with potassium spheres in the presence of a slight excess of 2.2.2-cryptand, affords the quantitative conversion of 1 into the uranium(II) monoarene complex [K(2.2.2-crypt)][(((Ad,Me) ArO)3 mes)U] (1-K). The molecular and electronic structure of 1-K was established experimentally by single-crystal X-ray diffraction, variable-temperature (1) H NMR and X-band EPR spectroscopy, solution-state and solid-state magnetism studies, and optical absorption spectroscopy. The electronic structure of the complex was further investigated by DFT calculations. The complete body of evidence confirms that 1-K is a uranium(II) monoarene complex with a 5f (4) electronic configuration supported by δ backbonding and that the nearly reversible, room-temperature reduction observed for 1 at -2.495 V vs. Fc/Fc(+) is principally metal-centered.
Covalent An-Cl bonding in series of +4 actinide hexachlorides, AnCl6 2-(An IV = U, Th, Np, Pu) have been characterized using Cl K-edge XAS and DFT. The results suggest that the 6d-orbital mixing is more substantial than that of the 5f-orbital. Additionally, the results indicate that 5fcovalent bonding with the Cl 3p orbitals is more substantial for Pu than for Th, U, and Np.
Nd, like U, prefers a f4 configuration with the tris(aryloxide)arene ligand rather than the 4f35d1 configuration found in tris(cyclopentadienyl) complexes.
Synthetic strategies to yield molecular complexes of high-valent lanthanides, other than the ubiquitous Ce 4+ ion, are exceptionally rare, and thorough, detailed characterization in these systems is limited by complex lifetime and reaction and isolation conditions. The synthesis of high-symmetry complexes in high purity with significant lifetimes in solution and the solid state is essential for determining the role of ligand-field splitting, multiconfigurational behavior, and covalency in governing the reactivity and physical properties of these potentially technologically transformative tetravalent ions. We report the synthesis and physical characterization of an S 4 symmetric, fourcoordinate tetravalent terbium complex, [Tb(NP(1,2-bis-t Budiamidoethane)(NEt 2 )) 4 ] (where Et is ethyl and t Bu is tert-butyl). The ligand field in this complex is weak and the metal− ligand bonds sufficiently covalent so that the tetravalent terbium ion is stable and accessible via a mild oxidant from the anionic, trivalent, terbium precursor, [(Et 2 O)K][Tb(NP(1,2-bis-t Bu-diamidoethane)(NEt 2 )) 4 ]. The significant stability of the tetravalent complex enables its thorough characterization. The stepwise development of the supporting ligand points to key ligand control elements for further extending the known tetravalent lanthanide ions in molecular complexes. Magnetic susceptibility, electron paramagnetic resonance (EPR) spectroscopy, X-ray absorption near-edge spectroscopy (XANES), and density functional theory studies indicate a 4f 7 ground state for [Tb(NP(1,2-bis-t Bu-diamidoethane)(NEt 2 )) 4 ] with considerable zero-field splitting, demonstrating that magnetic, tetravalent lanthanide ions engage in covalent metal−ligand bonds. This result has significant implications for the use of tetravalent lanthanide ions in magnetic applications since the observed zero-field splitting is intermediate between that observed for the trivalent lanthanides and for the transition metals. The similarity of the multiconfigurational behavior in the ground state of [Tb(NP(1,2-bis-t Bu-diamidoethane)(NEt 2 )) 4 ] (measured by Tb L 3 -edge XAS) to that observed in TbO 2 implicates ligand control of multiconfigurational behavior as a key component of the stability of the complex.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.